• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [16386 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2016     NIHR Horizon Scanning Centre (NIHR HSC) Methoxyflurane (Penthrox) for emergency relief of moderate to severe pain
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Magnetic sphincter augmentation device (MSAD) in patients with gastroesophageal reflux disease (GERD)
2016     National Institute for Health and Care Excellence (NICE) Percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back pain. NICE interventional procedures guidance 545
2016     NIHR Horizon Scanning Centre (NIHR HSC) CPX-351 (VYXEOS) for elderly patients with newly diagnosed acute myeloid leukaemia – first line
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Obinutuzumab (Gazyvaro®) in combination with bendamustine for the treatment of relapsed/refractory follicular lymphoma (FL)
2016     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Ataluren (expiry of the deadline)]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Carfilzomib (Kyprolis) in combination with dexamethasone for relapsed multiple myeloma – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) ATIR101 for patients with haematological malignancy who are candidates for haematopoietic stem cell transplantation – adjunctive therapy
2016     Norwegian Institute of Public Health (NIPH) Health technology assessment of four drugs for patients with metastatic castration resistant prostate cancer
2016     NIHR Horizon Scanning Centre (NIHR HSC) Buparlisib with fulvestrant for postmenopausal women with metastatic oestrogen-receptor positive, HER2 negative breast cancer – third line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Carfilzomib (Kyprolis) in combination with melphalan and prednisone for multiple myeloma – first line
2016     NIHR Health Technology Assessment programme Palbociclib for treating metastatic, hormone receptor-positive, HER2-negative breast cancer [ID915]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Reolysin for advanced or metastatic pancreatic cancer – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Dabrafenib (Tafinlar) with trametinib (Mekinist) for BRAF V600 mutation positive melanoma – adjuvant therapy
2016     NIHR Horizon Scanning Centre (NIHR HSC) Irinotecan-eluting beads (DC Bead, DC Bead M1 and DC Bead Lumi) for liver metastases secondary to colorectal cancer
2016     NIHR Horizon Scanning Centre (NIHR HSC) Lifitegrast for dry eye disease
2016     NIHR Horizon Scanning Centre (NIHR HSC) Idelalisib in combination with bendamustine and rituximab for indolent non-Hodgkin lymphoma – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for gastric and gastroesophageal junction adenocarcinoma – third and fourth line
2016     NIHR Horizon Scanning Centre (NIHR HSC) rhPTH (Natpar) for hypoparathyroidism – adjunctive therapy
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ozanimod for relapsing remitting multiple sclerosis
2016     NIHR Horizon Scanning Centre (NIHR HSC) C3BS-CQR-1 (C-Cure) for heart failure secondary to ischaemic cardiomyopathy
2016     NIHR Horizon Scanning Centre (NIHR HSC) Siponimod for secondary progressive multiple sclerosis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Veliparib with carboplatin and paclitaxel for early-stage triple negative breast cancer ─ neoadjuvant therapy
2016     NIHR Health Technology Assessment programme ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir, GS-9857 and velpatasvir triple therapy for chronic hepatitis C
2016     NIHR Health Services and Delivery Research programme Transforming community health services for children and young people who are ill: a quasi-experimental evaluation
2016     NIHR Health Technology Assessment programme TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer
2016     NIHR Health Technology Assessment programme Non-pharmacological treatments for stuttering in children and adults: a systematic review and evaluation of clinical effectiveness, and exploration of barriers to successful outcomes
2016     NIHR Horizon Scanning Centre (NIHR HSC) Vonicog alfa for severe von Willebrand disease
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ultra-low-dose Danazol (Optina; Vasaloc) for diabetic macular oedema
2016     NIHR Health Technology Assessment programme Tumour necrosis factor- inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Latanoprostene bunod for open-angle glaucoma or ocular hypertension – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Adalimumab (Humira) for uveitis in paediatric patients – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Allantoin (Zorblisa) for lesions associated with epidermolysis bullosa – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Diclectin (doxylamine succinate and pyridoxine hydrochloride) for the treatment of nausea and vomiting in pregnancy
2016     Health Quality Ontario (HQO) Skin testing for allergic rhinitis: OHTAC recommendation
2016     Health Quality Ontario (HQO) Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: OHTAC recommendation
2016     NIHR Health Services and Delivery Research programme Health Equity Indicators for the English NHS: a longitudinal whole-population study at the small-area level
2016     Health Quality Ontario (HQO) Skin testing for allergic rhinitis: a health technology assessment
2016     NIHR Health Services and Delivery Research programme Characterising the nature of primary care patient safety incident reports in the England and Wales National Reporting and Learning System: a mixed-methods agenda-setting study for general practice
2016     Health Quality Ontario (HQO) Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: a systematic review
2016     NIHR Public Health Research (PHR) programme Development and evaluation of an intervention providing insight into the tobacco industry to prevent smoking uptake: a mixed-methods study
2016     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation
2016     Health Quality Ontario (HQO) Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: an economic analysis
2016     Health Quality Ontario (HQO) Interventions to improve access to primary care for people who are homeless: a systematic review
2016     HTA Unit, University of Calgary Laser interstitial thermal therapy for treating intracranial lesions and epilepsy: a health technology assessment and policy analysis
2016     HTA Unit, University of Calgary Pineal gland cysts: an evidence synthesis
2016     HTA Unit, University of Calgary Pineal gland cysts: an evidence synthesis summary
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Atezolizumab (Tecentriq™) for the treatment of locally advanced and metastatic urothelial carcinoma.
2016     HAYES, Inc. Allogeneic hematopoietic stem cell transplantation for sickle cell disease in children
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Venetoclax (Venclexta™) for the treatment of relapsed or refractory chronic lymphocytic leukaemia (CLL) with chromosome 17p deletion
2016     HAYES, Inc. Comparative effectiveness of fiberoptic phototherapy for hyperbilirubinemia in preterm infants
2016     NIHR Horizon Scanning Centre (NIHR HSC) Atezolizumab in combination with bevacizumab for advanced renal cell carcinoma – first line
2016     HAYES, Inc. Comparative effectiveness of fiberoptic phototherapy for hyperbilirubinemia in term infants
2016     NIHR Horizon Scanning Centre (NIHR HSC) Capmatinib for advanced, EGFR wild type, c-Met amplified, non-small cell lung cancer – second or third line
2016     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for post-operative opioid prescribing
2016     HAYES, Inc. Hypoglossal nerve stimulation for the treatment of obstructive sleep apnea
2016     NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (XGEVA) for hypercalcaemia of malignancy – second line
2016     Penn Medicine Center for Evidence-based Practice (CEP) Mindfulness-based stress reduction interventions for nurses
2016     NIHR Health Technology Assessment programme The Men's Safer Sex project: intervention development and feasibility randomised controlled trial of an interactive digital intervention to increase condom use in men
2016     HAYES, Inc. Implantable cardiac loop recorders for diagnosis and management of syncope in adults
2016     NIHR Horizon Scanning Centre (NIHR HSC) Depatuxizumab mafodotin for recurrent EGFR-amplified glioblastoma multiforme
2016     National Institute for Health and Care Excellence (NICE) XprESS multi sinus dilation system for treating chronic sinusitis. NICE medical technologies guidance 30
2016     HAYES, Inc. In-hospital patient bathing with 2% chlorhexidine gluconate cloths (Sage Products Inc.) for prevention of hospital-acquired infections
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ibrutinib (Imbruvica) with rituximab for Waldenström's macroglobulinaemia – untreated or previously treated patients
2016     National Institute for Health and Care Excellence (NICE) Spectra Optia for automatic red blood cell exchange in people with sickle cell disease. NICE medical technologies guidance 28
2016     NIHR Health Technology Assessment programme Accuracy of fundus autofluorescence imaging for the diagnosis and monitoring of retinal conditions: a systematic review
2016     NIHR Horizon Scanning Centre (NIHR HSC) Nintedanib (Vargatef) for metastatic colorectal cancer – second and subsequent line
2016     HAYES, Inc. Intragastric balloons for treatment of obesity
2016     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) and ipilimumab (Yervoy) for advanced or metastatic renal cell carcinoma – first line
2016     Penn Medicine Center for Evidence-based Practice (CEP) Anticoagulation therapy guidelines for open heart mechanical valve replacement patients
2016     NIHR Horizon Scanning Centre (NIHR HSC) NBTXR-3 for advanced soft tissue sarcoma – first line
2016     HAYES, Inc. Low-level laser therapy for carpal tunnel syndrome
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pertuzumab for metastatic HER2-positive gastric cancer – first line
2016     NIHR Health Technology Assessment programme The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trial
2016     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for advanced or metastatic malignant melanoma with a c-kit juxtamembrane mutation
2016     HAYES, Inc. Magnetic resonance elastography for detecting and staging liver fibrosis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ciraparantag for haemorrhage in patients receiving new oral anticoagulants
2016     NIHR Health Technology Assessment programme tegrated sensor-augmented pump therapy system [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Olaparib (Lynparza) for metastatic breast cancer with germline BRCA mutation – second line
2016     HAYES, Inc. Multimodal Intraoperative Monitoring (MIOM) during surgery for scoliosis and spinal deformities
2016     NIHR Horizon Scanning Centre (NIHR HSC) Autologous CD34+ hematopoietic stem cells transduced ex vivo with lentiviral vector encoding for the human ADA gene for severe combined immunodeficiency caused by adenosine deaminase deficiency
2016     NIHR Health Technology Assessment programme Intervention Now to Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, and qualitative and realist synthesis of implementation factors and user engagement
2016     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-a) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-a-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn's disease: systematic reviews and economic modelling
2016     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for stage IV or recurrent PD-L1 positive non-small cell lung cancer – first line
2016     HAYES, Inc. Multimodality Intraoperative Monitoring (MIOM) during cervical spinal surgery
2016     NIHR Horizon Scanning Centre (NIHR HSC) Diazoxide choline controlled-release for Prader-Willi syndrome – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for stage IV or recurrent non-small cell lung cancer – first line
2016     HAYES, Inc. Novocure (tumor treating fields)
2016     NIHR Horizon Scanning Centre (NIHR HSC) Eculizumab (Soliris) for relapsing neuromyelitis optica spectrum disorders
2016     Penn Medicine Center for Evidence-based Practice (CEP) Best practices for preventing aspiration pneumonia in hospital patients
2016     NIHR Horizon Scanning Centre (NIHR HSC) Rucaparib for advanced BRCA-mutated ovarian cancer
2016     HAYES, Inc. Pelvic floor electrical stimulation for the treatment of urinary incontinence
2016     NIHR Horizon Scanning Centre (NIHR HSC) XG 102 for post-operative inflammation and pain following cataract surgery
2016     Penn Medicine Center for Evidence-based Practice (CEP) Endotracheal tubes for subglottic suctioning
2016     NIHR Horizon Scanning Centre (NIHR HSC) Reolysin for relapsed or refractory multiple myeloma
2016     HAYES, Inc. Percutaneous pulmonary valve implantation for right ventricular outflow tract defects
2016     NIHR Horizon Scanning Centre (NIHR HSC) Eculizumab (Soliris) for prevention of delayed graft function after kidney transplantation in adult patients at increased risk – first line
2016     Penn Medicine Center for Evidence-based Practice (CEP) Faculty development programs for underrepresented minority faculty
2016     NIHR Health Technology Assessment programme Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis